Formoterol: a review of its use in chronic obstructive pulmonary disease.

@article{Cheer2002FormoterolAR,
  title={Formoterol: a review of its use in chronic obstructive pulmonary disease.},
  author={Susan M. Cheer and Lesley J. Scott},
  journal={American journal of respiratory medicine : drugs, devices, and other interventions},
  year={2002},
  volume={1 4},
  pages={
          285-300
        }
}
Inhaled formoterol is a long-acting selective beta2-adrenoceptor agonist, with an onset of action of 5 minutes postdose and a bronchodilator effect that lasts for at least 12 hours. Statistically significant and clinically relevant (>120 ml) improvements in lung function [assessed using standardized/normalized area under the forced expiratory volume in 1 second (FEV1) versus time curve (AUC FEV1)] were observed with inhaled formoterol 12 microg twice daily (the approved dosage in the US… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 14 CITATIONS

Budesonide/Formoterol Turbuhaler®

VIEW 3 EXCERPTS
CITES BACKGROUND